-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

Benzinga·12/08/2025 16:16:49
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.